Heteroaryl piperidine and heteroaryl piperazine derivatives as fungicides

US9975889B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9975889-B2
Application numberUS-201615339576-A
CountryUS
Kind codeB2
Filing dateOct 31, 2016
Priority dateOct 27, 2010
Publication dateMay 22, 2018
Grant dateMay 22, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Heteroarylpiperidine and -piperazine derivatives of the formula (I) in which the symbols A, X, Y, L 1 , L 2 , G, Q, p, R 1 , R 2 and R 10 are each as defined in the description, and salts, metal complexes and N-oxides of the compounds of the formula (I), and the use thereof for controlling phytopathogenic harmful fungi and processes for preparing compounds of the formula (I).

First claim

Opening claim text (preview).

The invention claimed is: 1. A compound of the formula (I) in which the radicals are each defined as follows: A is phenyl which may contain up to two substituents, where the substituents are each independently selected from the following list: halogen, cyano, hydroxyl, —NR 3 R 4 , —C(═O)NR 3 R 4 , nitro, C 1 -C 6 -alkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -alkynyl, C 3 -C 8 -cycloalkyl, C 1 -C 6 -haloalkyl, C 2 -C 6 -haloalkenyl, C 2 -C 6 -haloalkynyl, C 3 -C 6 -halocycloalkyl, C 1 -C 4 -alkoxy, C 1 -C 4 -haloalkoxy, C 1 -C 4 -alkenyloxy, C 1 -C 4 -alkynyloxy, C 1 -C 4 -alkylthio, C 1 -C 4 -alkylsulphonyl, C 1 -C 4 -haloalkylthio, C 1 -C 4 -haloalkylsulphonyl, C 1 -C 4 -alkoxy-C 1 -C 6 -alkyl, hydroxy-C 1 -C 4 -alkyl, C 1 -C 6 -alkylcarbonyl, C 1 -C 6 -alkoxycarbonyl, C 1 -C 6 -alkylcarbonyloxy or —C(═O)H, or A is a heteroaromatic radical selected from the following group: furan-2-yl, furan-3-yl, thiophen-2-yl, thiophen-3-yl, isoxazol-3-yl, isoxazol-4-yl, isoxazol-5-yl, pyrrol-1-yl, pyrrol-2-yl, pyrrol-3-yl, oxazol-2-yl, oxazol-4-yl, oxazol-5-yl, thiazol-2-yl, thiazol-4-yl, thiazol-5-yl, isothiazol-3-yl, isothiazol-4-yl, isothiazol-5-yl, pyrazol-1-yl, pyrazol-3-yl, pyrazol-4-yl, imidazol-1-yl, imidazol-2-yl, imidazol-4-yl, 1,2,3-triazol-1-yl, 1,2,4-triazol-1-yl, pyridin-2-yl, pyridin-3-yl, pyridin-4-yl, pyridazin-3-yl, pyridazin-4-yl, pyrazin-2-yl, pyrazin-3-yl, pyrimidin-2-yl, pyrimidin-4-yl or pyrimidin-5-yl which may contain up to two substituents, where the substituents are each independently selected from the following list: substituents on carbon: halogen, cyano, hydroxyl, nitro, —NR 3 R 4 , C 1 -C 6 -alkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -alkynyl, C 3 -C 6 -cycloalkyl, C 1 -C 6 -haloalkyl, C 2 -C 6 -haloalkenyl, C 2 -C 6 -haloalkynyl, C 3 -C 6 -halocycloalykl, C 1 -C 4 -alkoxy, C 1 -C 4 -haloalkoxy, C 1 -C 4 -alkylthio, C 1 -C 4 -alkylsulphonyl, C 1 -C 4 -haloalkylthio, C 1 -C 4 -haloalkylsulphonyl, C 1 -C 4 -alkoxy-C 1 -C 4 -alkyl, hydroxy-C 1 -C 4 -alkyl, C 1 -C 6 -alkylcarbonyl, C 1 -C 6 -alkoxycarbonyl, C 1 -C 6 -alkylcarbonyloxy or phenyl, substituents on nitrogen: C 1 -C 6 -alkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -alkynyl, C 1 -C 6 -haloalkyl, C 2 -C 6 -haloalkenyl, C 2 -C 6 -haloalkynyl, C 3 -C 10 -cycloalkyl-C 1 -C 6 -alkyl, C 1 -C 6 -haloalkylcarbonyl, phenyl, benzyl, C 1 -C 4 -alkylsulphonyl, C 1 -C 4 -haloalkylsulphonyl, phenylsulphonyl, —C(═O)H, or C 1 -C 6 -alkylcarbonyl, L 1 is —NH—, Y is oxygen, X is carbon, R 2 is hydrogen, p is 0, G is where the bond identified by “v” is bonded directly to X and where the bond identified by “w” is bonded directly to Q, R G1 is hydrogen, Q is R 5 is hydrogen, L 2 is a direct bond, where the bond identified by “x” is bonded directly to G, and the bond identified by “y” is bonded directly to L 2 , R 1 is phenyl which is substituted once by a Z 4 substituent and may additionally optionally have further substitution, where the additional substituents are each independently selected from Z 4 and Z 1-1 , Z 4 is C 1 -C 3 -alkoxy-C 2 -C 3 -alkoxy-C 1 -C 3 -alkyl, C 1 -C 4 -alkylsulphinyl-C 1 -C 2 -alkyl, C 1 -C 4 -alkylsulphonyl-C 1 -C 2 -alkyl, C 1 -C 4 -haloalkoxy-C 1 -C 2 -alkyl, C 2 -C 6 -alkenyloxy, C 2 -C 6 -alkynyloxy, C 1 -C 4 -alkoxy-C 1 -C 4 -alkoxy, or C 1 -C 4 -alkylsulphonylamino, Z 1-1 is halogen, C 1 -C 6 -alkyl, or C 1 -C 6 -haloalkyl; and/or a salt, metal complex and/or an N-oxide thereof. 2. The compound of the formula (I) and/or a salt, metal complex and/or an N-oxide thereof according to claim 1 , wherein the radical definitions are as follows: A is phenyl which may contain up to two substituents, where the substituents are each independently selected from the following list: methyl, ethyl, iodine, chlorine, bromine, fluorine, methoxy, ethoxy, difluoromethyl or trifluoromethyl or A is pyrazol-1-yl which may contain up to two substituents, where the substituents are each independently selected from the following list: methyl, ethyl, chlorine, bromine, fluorine, difluoromethyl or trifluoromethyl. 3. The compound of the formula (I) and/or a salt, metal complex and/or an N-oxide thereof according to claim 1 , wherein A is 5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl, 3,5-bis(trifluoromethyl)-1H-pyrazol-1-yl, 3-(difluoromethyl)-5-methyl-1H-pyrazol-1-yl, 5-(difluoromethyl)-3-methyl-1H-pyrazol-1-yl, 2,5-bis(difluoromethyl)phenyl, 2,5-dimethylphenyl or 5-chloro-2-methylphenyl. 4. The compound of the formula (I) and/or a salt, metal complex and/or an N-oxide thereof according to claim 1 , wherein Z 4 is C 2 -C 6 -alkenyloxy, C 2 -C 6 -alkynyloxy or C 1 -C 4 -alkylsulphonylamino, and Z 1-1 is selected from halogen and C 1 -C 6 -alkyl. 5. The compound of the formula (I) and/or a salt, metal complex and/or an N-oxide thereof according to claim 1 , wherein R 1 is 2-(allyloxy)phenyl, 3-(allyloxy)phenyl, 3-(allyloxy)-2,6-difluorophenyl, 2-(allyloxy)-4-methylphenyl, 2-(allyloxy)-4,6-dichlorophenyl, 2-(allyloxy)-6-fluorophenyl, 2-(allyloxy)-6-chlorophenyl, 2-(allyloxy)-3-fluorophenyl, 3-formylphenyl, 2-formylphenyl, 2-fluoro-6-formylphenyl, 2-(prop-2-yn-1-yloxy)phenyl, 2, 6-difluoro-3-(prop-2-yn-1-yloxy)phenyl, 3-fluoro-2-(prop-2-yn-1-yloxy)phenyl, 3-(prop-2-yn-1-yloxy)phenyl, 2-chloro-6-(prop-2-yn-1-yloxy)phenyl, 4-chloro-2-(prop-2-yn-1-yloxy)phenyl, 2,4-dichloro-6-(prop-2-yn-1-yloxy)phenyl, 2-fluoro-6-(prop-2-yn-1-yloxy)phenyl, 4-methyl-2-(prop-2-yn-1-yloxy)phenyl, 2-(but-2-yn-1-yloxy)-4-methoxyphenyl or 2-[(methyl-sulphonyl)amino]phenyl. 6. A compound of the formula (VII) and/or a salt, metal complex and/or an N-oxide thereof, in which the radicals are each as defined as follows: X is carbon, R 2 is hydrogen, p is 0, G is where the bond identified by “v” is bonded directly to X and where the bond identified by “w” is bonded directly to Q, R G1 is hydrogen, Q is R 5 is hydrogen, L 2 is a direct bond, where the bond identified by “x” is bonded directly to G, and the bond identified by “y” is bonded directly to L 2 , R 1 is phenyl which is substituted once by a Z 4 substituent and may additionally optionally have further substitution, where the additional substituents are each independently selected from Z 4 and Z 1-1 , Z 4 is C 1 -C 3 -alkoxy-C 2 -C 3 -alkoxy-C 1 -C 3 -alkyl, C 1 -C 4 -alkylsulphinyl-C 1 -C 2 -alkyl, C 1 -C 4 -alkylsulphonyl-C 1 -C 2 -alkyl, C 1 -C 4 -haloalkoxy-C 1 -C 2 -alkyl, C 2 -C 6 -alkenyloxy, C 2 -C 6 -alkynyloxy, C 1 -C 4 -alkoxy-C 1 -C 4 -alkoxy, or C 1 -C 4 -alkylsulphonylamino, Z 1-1 is halogen, C 1 -C 6 -alkyl, or C 1 -C 6 -haloalkyl; and W 13 is a leaving group. 7. A compound of the formula (XVIId) and/or a salt, metal complex and/or an N-oxide thereof, in which the symbol W 6 is acetyl, C 1 -C 4 alkoxycarbonyl

Assignees

Inventors

Classifications

  • 1,3-Thiazoles; Hydrogenated 1,3-thiazoles · CPC title

  • C07D417/14Primary

    containing three or more hetero rings · CPC title

  • five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,2 · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9975889B2 cover?
Heteroarylpiperidine and -piperazine derivatives of the formula (I) in which the symbols A, X, Y, L 1 , L 2 , G, Q, p, R 1 , R 2 and R 10 are each as defined in the description, and salts, metal complexes and N-oxides of the compounds of the formula (I), and the use thereof for controlling phytopathogenic harmful fungi and processes for preparing compounds of the fo…
Who is the assignee on this patent?
Bayer Ip Gmbh
What technology area does this patent fall under?
Primary CPC classification C07D417/14. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue May 22 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 3 related publications on this page (citations in our corpus or others sharing the same primary CPC).